ARDELYX INC reports a Return on Equity (ROE) of -39.07%.

What is ARDX's dividend yield?

ARDELYX INC offers a dividend yield of 0.00%.

What is ARDX's Quality Score?

Our AI rates ARDX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ARDX?

Our AI Timing Score for ARDX is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ARDX belong to?

ARDELYX INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

ARDX (NASDAQ) Stock Analysis | ARDELYX INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ARDX AI Analysis Summary

Our AI summary for ARDX: ARDELYX INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -39.07%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ARDX

ARDELYX INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 84

USD 4.95

-0.09 (-1.79%) Day Change

Watchlist Portfolio Compare Chart

1.38

D/E

-39.1%

ROE

-11.5%

ROA

0.00%

Div Yield

ARDELYX INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.95 Price -0.09 (-1.79%) Day Change	NEWS SCORE: 84

ARDX, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

38%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	84
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.95
PBV / Sector	8.38 / 5.20
Earning Per Share	-0.23

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	13.68 M GREAT
Average 1W Daily Value	10.97 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

43%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-13.58 / 98.71
NPM Average (%) / Sector	-44.47 / -1,721.76
NPM Change Average (%) / Sector	-29.50 / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-11.51 / 27.02
ROA Average (%) / Sector	-18.07 / -368.17
ROA Change Average (%) / Sector	-16.58 / 5,404.12
ROE (%) / Sector	-39.07 / 3.47
ROE Average (%) / Sector	-41.30 / 6.51
ROE Change Average (%) / Sector	-3.94 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 07:59:29
Symbol	ARDX
Name	ARDELYX INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	247.03 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,245.03 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 400 Fifth Avenue, Waltham, MA, United States, 02451

Phone: 510 745 1700

Website: https://www.ardelyx.com

Employees: 489

Sector: Healthcare >> Biotechnology

Description: Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.